Cargando…
Nivolumab for Methotrexate-associated Classic Hodgkin's Lymphoma in a Rheumatoid Arthritis Patient
Nivolumab exerts therapeutic activity in patients with classic Hodgkin's lymphoma (CHL) but may cause several types of immune-related adverse events. Some rheumatoid arthritis (RA) patients develop CHL during methotrexate therapy (MTX-CHL); however, the efficacy and safety of nivolumab for thes...
Autores principales: | Tanaka, Keisuke, Kuboki, Mai, Koi, Satoshi, Toyota, Shigeo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118370/ https://www.ncbi.nlm.nih.gov/pubmed/31761888 http://dx.doi.org/10.2169/internalmedicine.3772-19 |
Ejemplares similares
-
A case of classic Hodgkin lymphoma arising after remission of methotrexate-associated follicular lymphoma
por: Ueda, Yayoi, et al.
Publicado: (2023) -
Oral non-Hodgkin’s lymphoma in a patient with rheumatoid arthritis
treated with etanercept and methotrexate
por: Georgakopoulou, Eleni A., et al.
Publicado: (2015) -
FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma
por: Kasamon, Yvette L., et al.
Publicado: (2017) -
Clinicopathological analysis of methotrexate‐associated lymphoproliferative disorders: Comparison of diffuse large B‐cell lymphoma and classical Hodgkin lymphoma types
por: Gion, Yuka, et al.
Publicado: (2017) -
A case report of using nivolumab for a malignant melanoma patient with rheumatoid arthritis
por: Kageyama, Shun-Ichiro, et al.
Publicado: (2016)